Michael Fenn, Ph.D., is a highly accomplished professional with a diverse background in biomedical engineering, entrepreneurship, and business development. He currently serves as the Director of External Innovation at Dewpoint Therapeutics, where he is responsible for sourcing and evaluating emerging scientific, technological, and therapeutic assets of strategic interest. With extensive experience in startups, venture capital, and strategic partnerships, Fenn has contributed to projects that have collectively raised $35M+ in venture funding, formed strategic partnerships, achieved FDA clearance, scale-up to GMP manufacturing, and successful exit. Previously, he served as Director of Healthcare & Life Sciences at Harvard Innovation Labs and cofounded the Biomedical Engineering Department at Florida Institute of Technology. Fenn's expertise and skills are diverse, including business development, IP portfolio development, data-driven approaches, building value, leading diverse teams, and strategic planning.